SG Talk

Full Version: Moderna says FDA needs more time to review its Covid vaccine for 12-17
You're currently viewing a stripped down version of our content. View the full version with proper formatting.
The agency is looking specifically at the risk of myocarditis in kids, Moderna said in a statement Sunday, and the review may not be completed before January 2022. Myocarditis is the inflammation of the heart muscle.


https://www.cnbc.com/2021/10/31/covid-mo...teens.html